H7N9 Influenza Clinical Trials Database - Free Access to 4 Studies
Access comprehensive clinical trial information for H7N9 Influenza through Pure Global AI's free database. This collection includes 4 clinical trials across multiple phases including Phase 1, Early Phase 1, Phase 2. Currently, 1 trials are actively recruiting participants.
Research for H7N9 Influenza is being conducted in China, Australia, United States of America and more. Leading sponsors include Shanghai Institute Of Biological Products and Novartis Vaccines. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Influenza A (H7N9) Vaccine Delivered Intradermally by High-density Microarray Patch (HD-MAP)
A Study of An Adjuvanted Inactivated H7N9 Influenza Vaccine
A Clinical Trail Of An Adjuvanted Inactivated H7N9 Influenza Vaccine
Dose-finding Study of Four Dosage Levels of an H7N9 Influenza Vaccine in Adults Between Ages of 18 Years and 65 Years
Pure Global AI provides free access to 4 clinical trials studying H7N9 Influenza, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 3+ countries.
Top research sponsors include Shanghai Institute Of Biological Products, Novartis Vaccines, Vaxxas Pty Ltd, among others.